Registration, quality assurance and the shape of a medicines contract
A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programmes -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.
Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.
The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and programme funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.
This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.
Who buys pharmaceuticals in Malta?
GlobalGov holds 44 pharmaceuticals records from 4 distinct buying organisations in Malta. The most frequent publishers are Department of Contracts (21 records); Sectoral Procurement Directorate (11 records); Department of Contracts (5 records); Water Services Corporation (5 records); Department Of Contracts (1 record); mairie de case-pilote (1 record). Between them the 6 largest account for 100% of everything published, so buying here is concentrated in a few authorities.
| Buying organisation | Records | Share |
|---|---|---|
| Department of Contracts | 21 | 48% |
| Sectoral Procurement Directorate | 11 | 25% |
| Department of Contracts | 5 | 11% |
| Water Services Corporation | 5 | 11% |
| Department Of Contracts | 1 | 2.3% |
| mairie de case-pilote | 1 | 2.3% |
What are pharmaceuticals contracts worth in Malta?
20 of the 44 records publish a contract value. The median is $1.4M and the largest single published value is $9.3M. By size, 7 between $100k and $1M, 13 between $1M and $10M. The remaining 24 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.
| Contract size | Records | Share of priced |
|---|---|---|
| under $100k | 0 | 0.0% |
| between $100k and $1M | 7 | 35% |
| between $1M and $10M | 13 | 65% |
| above $10M | 0 | 0.0% |
How long do bidders get to respond to pharmaceuticals tenders in Malta?
Across the 19 Malta pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 37 days. A quarter of them allowed 34 days or fewer and a quarter stayed open for more than 40. Not one of them closed within a fortnight of being published, so the window on this market is consistently workable.
How often are pharmaceuticals tenders published in Malta?
Malta published 6 notices in this category in the last twelve months. Over the last three years there were 19, spread across 29 separate months of activity since 24 October 2019. September is historically the busiest month. The most recent was published 12 August 2026.
How does Malta compare with other pharmaceuticals markets?
Among the 39 countries where GlobalGov holds a comparable pharmaceuticals market, Malta ranks 36th by number of records. The largest is Germany (4,115 records against 44 here). Within Malta itself, pharmaceuticals is the 20th largest of the 35 procurement categories tracked here.
Where do the Malta pharmaceuticals records on this page come from?
These 44 records are collected from 1 official source: TED (44). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-01.
Most recent Pharmaceuticals tenders in Malta
None of these are open for bids now — they are the most recent records GlobalGov holds for this market, kept here so the shape of a typical pharmaceuticals notice in Malta is visible. Set an alert to be told when the next one opens.
CT2373/2025 - Framework Contract for the Supply of Glucose Reagent Strips and Consumables with Equipment on Loan (EOL) for Type 2 Diabetes Community Testing and - Glucose Reagent Strips and Consumables with Equipment on Loan (EOL) for Blind People with Type 1 Diabetes
Malta – Oxygen – SPD4/2024/029 - Re-Issue - Framework Contract for the Supply and Delivery of Bulk Liquid Oxygen for Three (3) Years to Saint Vincent De Paul, Long Term Care Facility, Luqa
Malta-Floriana: Oxygen
Martinique-Case-Pilote: Child daycare services
Other procurement categories in Malta
Pharmaceuticals procurement in other markets
Never Miss a Malta Government Contract
Finding Malta tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new pharmaceuticals opportunity is published there.
Start Free Trial